BACKGROUND: The human hippocampus comprises a number of interconnected histologically and functionally distinct subfields, which may be differentially influenced by cerebral pathology. Automated techniques are now available that estimate hippocampal subfield volumes using in vivo structural MRI data. To date, research investigating the influence of cerebral β-amyloid deposition-one of the earliest hypothesised changes in the pathophysiological continuum of Alzheimer's disease-on hippocampal subfield volumes in cognitively normal older individuals, has been limited. METHODS: Using cross-sectional data from 408 cognitively normal individuals born in mainland Britain (age range at time of assessment = 69.2-71.9 years) who underwent cognitive a...
BackgroundThe hippocampus and hippocampal subfields have been found to be diversely affected in Alzh...
AbstractBackgroundHippocampal atrophy is a well-known feature of Alzheimer's disease (AD), but sensi...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...
BACKGROUND: The human hippocampus comprises a number of interconnected histologically and functional...
We investigated the relationship between hippocampal subfield volumes and cortical amyloid-beta (Aβ)...
Amyloid-beta (Aβ) deposition is one of the main hallmarks of Alzheimer’s disease. The study assesse...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...
International audienceRecent advances in neuroimaging have highlighted the interest to differentiate...
Measures of amyloid-β (Aβ) and phosphorylated tau (p-tau) concentrations in cerebrospinal fluid are ...
International audienceBACKGROUND: Hippocampal atrophy is a well-known feature of Alzheimer's disease...
Histological studies have suggested differing involvement of the hippocampal subfields in ageing and...
Preclinical models of Alzheimer's disease (AD) suggest that volumetric reductions in medial temporal...
Dysfunction of the cholinergic basal forebrain (BF) system and amyloid- (A ) deposition are early pa...
Purpose Amyloid (Aβ) brain deposition can occur in cognitively normal individuals and is associated ...
BackgroundThe hippocampus and hippocampal subfields have been found to be diversely affected in Alzh...
AbstractBackgroundHippocampal atrophy is a well-known feature of Alzheimer's disease (AD), but sensi...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...
BACKGROUND: The human hippocampus comprises a number of interconnected histologically and functional...
We investigated the relationship between hippocampal subfield volumes and cortical amyloid-beta (Aβ)...
Amyloid-beta (Aβ) deposition is one of the main hallmarks of Alzheimer’s disease. The study assesse...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...
International audienceRecent advances in neuroimaging have highlighted the interest to differentiate...
Measures of amyloid-β (Aβ) and phosphorylated tau (p-tau) concentrations in cerebrospinal fluid are ...
International audienceBACKGROUND: Hippocampal atrophy is a well-known feature of Alzheimer's disease...
Histological studies have suggested differing involvement of the hippocampal subfields in ageing and...
Preclinical models of Alzheimer's disease (AD) suggest that volumetric reductions in medial temporal...
Dysfunction of the cholinergic basal forebrain (BF) system and amyloid- (A ) deposition are early pa...
Purpose Amyloid (Aβ) brain deposition can occur in cognitively normal individuals and is associated ...
BackgroundThe hippocampus and hippocampal subfields have been found to be diversely affected in Alzh...
AbstractBackgroundHippocampal atrophy is a well-known feature of Alzheimer's disease (AD), but sensi...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...